Table 3 Treatment costs (n = 30). The treatment’ costs represents the total value of US$7910.95 for 30 patients that used UDCA 300 mg capsules and tablets manufactured by the university hospital during all 24 weeks period. Using standard UDCA and considering the price for a public hospital, the costs of treatment was US$23,358.25

From: A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis